4-Piperidineethanol CAS 622-26-4 Purity >98.0% (GC) Factory

Short Description:

Chemical Name: 4-Piperidineethanol

CAS: 622-26-4

Purity: >98.0% (GC)

Colorless or White to Yellow Solid or Liquid

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4-Piperidineethanol (CAS: 622-26-4) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name	4-Piperidineethanol
Synonyms	4-(2-Hydroxyethyl)piperidine; 4-Ethanolpiperidine
CAS Number	622-26-4
CAT Number	RF-PI1921
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C7H15NO
Molecular Weight	129.20
Solubility	Solube in Methanol Almost Transparency
Condition to Avoid	Hygroscopic
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Colorless or White to Yellow Solid or Liquid
Purity / Analysis Method	>98.0% (GC)
Melting Point	48.0~52.0℃
Moisture (K.F)	<0.50%
Total Impurities	<2.00%
Infrared Spectrum	Conforms to Structure
Proton NMR Spectrum	Conforms to Structure
Solubility in MeOH	Almost Transparency
Test Standard	Enterprise Standard
Usage	Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

4-Piperidineethanol (CAS: 622-26-4), Reactant for synthesis of: Ursolic acid derivatives; Amodiaquine analogues for treatment of cerebral malaria; Spiroimidazolidinone NPC1L1 inhibitors; Piperazinyl glutamate pyridines as orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation; Neurokinin-2 receptor antagonists; Hepatitis C virus NS5B polymerase inhibitors. 4-Piperidineethanol have been used as a intermediate in the synthetic preparation of cellular-active allosteric inhibitors of FAK.